News

The EU-METAHEART COST Action was represented at the American Physiology Summit 2025, held this April in Baltimore, by Inês Falcão-Pires, George Kararigas and Antigone Lazou. Their participation contributed to the...

A tribute to our dearest friend and colleague, Prof. Ioanna Andreadou who passed away suddenly in January 2025. Our deepest condolences and heartfelt support go out to her family, her...

Membrane Contact Sites: Methodology, Biology & Pathology28 September–3 October 2025 | Monopoli (BA), Italy (Hybrid) Register by: 30 April 2025 Interested in discovering mitochondrial contact sites with other organelles, such...

Our COST action is pleased to sponsor the 22nd Annual Meeting of the Society for Heart and Vascular Metabolism (SHVM), to be held in Bordeaux, France, from Sunday, June 22nd...

The upcoming 3rd meeting of the management committee (MC3) of our COST Action will be held in Heraklion, Crete, Greece, on March 19 and 20, 2025. Please take a look...

Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine healthspan and lifespan. The circulatory system not only...

Join Us at the ESCI Annual Scientific Meeting 2025 in Genoa! We are pleased to invite you to the European Society for Clinical Investigation (ESCI) Annual Scientific Meeting, taking place...

Dear colleagues, May I take this opportunity to mention that we have a British Heart Foundation-funded position for a postdoctoral research fellow, available at the Hatter Cardiovascular Institute, UCL. Please...

It is a pleasure to announce the 2nd Postgraduate Course in Cardiometabolic Medicine, a timely and highly acclaimed educational programme conceived by Zurich Heart House – London Heart House, King’s...

Join the Cardiovascular Research and Tissue Engineering Summer School, a premier educational experience designed for students, early-career researchers, and healthcare professionals. 📅 When: June 30 – July 4, 2025📍 Where:...

New Research Highlight from EU-METAHEART consortium “Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage” by Panagiota-Efstathia Nicolau, Ioanna Andreadou and collaborators. The study...

A recent publication co-authored by core members of the EU-METAHEART COST Action focuses on the multifaceted mechanisms driving cardiac amyloidosis and explores potential therapeutic avenues. The paper, entitled “Mechanisms of...